OIH Introduces Revolutionary Treatment for Keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS)
Oman International Hospital is thrilled to announce the successful introduction of a groundbreaking procedure designed to treat keratoconus: Corneal Allogeneic Intrastromal Ring Implants (CAIRS). This innovative treatment marks a significant advancement in ophthalmology, offering new hope to patients suffering from this debilitating corneal disorder.
The CAIRS procedure involves inserting a specialized ring made from donor corneal tissue into the patient’s cornea using a femtosecond laser. This minimally invasive technique aims to improve corneal shape and vision quality, providing a viable alternative to more invasive procedures such as corneal transplants. Compared to artificial ring implants, CAIRS has demonstrated a better long-term safety profile, reducing the risk of complications and enhancing patient outcomes.
Leading the team for the first successful procedures was Dr. Ahmed Al-Maskari, Senior Consultant Ophthalmologist and Cataract, Cornea, and Refractive Surgeon at Oman Vision Centre. “We are thrilled to offer this advanced treatment to our patients. The Corneal Allogeneic Intrastromal Ring Implants provide an effective solution with quicker recovery times and reduced risk compared to traditional methods,” said Dr. Al-Maskari. “This is a significant step forward in our mission to provide cutting-edge eye care in Oman.”
Early patient outcomes have been highly promising, with notable improvements in vision. The procedure has been well-received and is expected to become a cornerstone treatment for those suffering from keratoconus.
“The launch of this procedure aligns with Oman International Hospital's commitment to excellence and innovation in healthcare,” said Mr. Marcelo Pereira, CEO of Oman International Hospital. “As one of the premier medical institutions in the region, the hospital continually strives to adopt the latest technologies and treatments to enhance patient outcomes and quality of life.”
Oman International Hospital remains dedicated to providing exceptional medical care to the community. With state-of-the-art facilities, a skilled team of healthcare professionals, and a commitment to patient well-being, we strive to deliver top-notch medical services.
-
Innov.Cell ended its successful participation in CPHI 2024
Innov.Cell, a subsidiary of IGHS, ended its successful participation in CPHI 2024, which took place in Milan, with a positive outcome. This year, CPHI was attended by more than 62,000 people and around 2,400 exhibitors from 166 countries. Throughout the event, Innov.Cell met with several potential partners, from R&D, investors, and distributors covering more than 50 countries.
Read more -
IGHS celebrates the inauguration of new Insparya Clinic at Oman International Hospital
With the presence of the distinguished shareholders, Sheika Amal Suhail Bahwan - representing Suhail Bahwan Group, and Mr. Fathi Al Balushi - representing Oman Brunei Investment Company, Insparya announces its strategic partnership with IGHS, inaugurating its new branch at Oman International Hospital.
Read more

